The CMS’ move to allow Medicare Advantage plans to require patients to try low-cost generic drugs before more expensive therapies on Part B could lead to poor health outcomes, causing an increase in ED use and inpatient admissions, providers say.
Medicare Part B change could lead to increased hospitalizations
